UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone

European heart journal, 2008-09, Vol.29 (17), p.2171-2179

2008

Volltextzugriff (PDF)

Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage

Circulation (New York, N.Y.), 2005-06, Vol.111 (23), p.3087-3094

2005

Volltextzugriff (PDF)

Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats

Journal of hypertension, 2005-02, Vol.23 (2), p.417-426

2005

Volltextzugriff (PDF)

Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP

Journal of hypertension, 2008-02, Vol.26 (2), p.322-333

2008

Volltextzugriff (PDF)

Renin inhibition with aliskiren : where are we now, and where are we going?

Journal of hypertension, 2006-02, Vol.24 (2), p.243-256

2006

Volltextzugriff (PDF)

Increased renal production of angiotensin II and thromboxane B2 in conscious diabetic rats

American journal of hypertension, 2005-04, Vol.18 (4), p.544-548

2005

Volltextzugriff (PDF)

Differences in AT2-receptor stimulation between AT1-receptor blockers valsartan and losartan quantified by renal interstitial fluid cGMP

Journal of hypertension, 2002-06, Vol.20 (6), p.1157-1163

2002

Volltextzugriff (PDF)

Synergistic effects of combined converting enzyme inhibition and angiotensin II antagonism on blood pressure in conscious telemetered spontaneously hypertensive rats

Journal of hypertension, 1998-06, Vol.16 (6), p.843-852

1998

Volltextzugriff (PDF)

Telemetric Monitoring of Cardiovascular Parameters in Conscious Spontaneously Hypertensive Rats

Journal of cardiovascular pharmacology, 1993-12, Vol.22 (6), p.897-905

1993

Volltextzugriff (PDF)

Combination of Low-Dose Valsartan and Enalapril Improves Endothelial Dysfunction and Coronary Reserve in Nω-Nitro-l-Arginine Methyl Ester–Treated Spontaneously Hypertensive Rats

Journal of cardiovascular pharmacology, 2002-11, Vol.40 (5), p.789-800

2002

Volltextzugriff (PDF)

Renal nitric oxide production is decreased in diabetic rats and improved by AT1 receptor blockade

Journal of hypertension, 2004-08, Vol.22 (8), p.1571-1577

2004

Volltextzugriff (PDF)

Effects of Valsartan and Hydrochlorothiazide Alone and in Combination on Blood Pressure and Heart Rate in Conscious-Telemetered Spontaneously Hypertensive Rats (SHR)

American journal of hypertension, 1998, Vol.11 (1), p.59-65

1998

Volltextzugriff (PDF)

The Angiotensin II Type 1 Receptor Mediates Renal Interstitial Content of Tumor Necrosis Factor-α in Diabetic Rats

Endocrinology (Philadelphia), 2003-06, Vol.144 (6), p.2229-2233

2003

Volltextzugriff (PDF)

Dipeptide sulfonamides as endothelin ETA/ETB receptor antagonists

Canadian journal of physiology and pharmacology, 2002-05, Vol.80 (5), p.464

2002

Volltextzugriff (PDF)

Effects of the Novel Dual Inhibitor of Neutral Endopeptidase and Angiotensin-Converting Enzyme, CGS 30440, on Blood Pressure and Cardiac Hypertrophy in Spontaneously Hypertensive Rats

Journal of cardiovascular pharmacology, 1997-11, Vol.30 (5), p.632-642, Article 632

1997

Volltextzugriff (PDF)

Hemodynamic Effects of Amlodipine and Benazeprilat in Spontaneously Hypertensive Rats

Journal of cardiovascular pharmacology, 1993-03, Vol.21 (3), p.405-411

1993

Volltextzugriff (PDF)

Effects of Aliskiren on Blood Pressure, Albuminuria, and (Pro)Renin Receptor Expression in Diabetic TG(mRen-2)27 Rats. Commentary

Hypertension (Dallas, Tex. 1979), 2008, Vol.52 (1)

2008

Volltextzugriff (PDF)

Functionally Distinct Endothelin B Receptors in Vascular Endothelium and Smooth Muscle

Biochemical and biophysical research communications, 1993-03, Vol.191 (2), p.459-464

1993

Volltextzugriff (PDF)

Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist. Effects on smooth muscle cell migration and proliferation after balloon catheter injury

The American journal of pathology, 1991-12, Vol.139 (6), p.1291-1296

1991

Volltextzugriff (PDF)

Diaminoindanes as Microsomal Triglyceride Transfer Protein Inhibitors

Journal of medicinal chemistry, 2001-12, Vol.44 (26), p.4677-4687

2001

Volltextzugriff (PDF)

Pharmacologic Profile of CGS 24128, a Potent, Long-Acting Inhibitor of Neutral Endopeptidase 24.11

Journal of cardiovascular pharmacology, 1994-03, Vol.23 (3), p.358-364

1994

Volltextzugriff (PDF)

Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats. Commentary

Hypertension (Dallas, Tex. 1979), 2005, Vol.46 (3), p.473-474

2005

Volltextzugriff (PDF)

Angiotensin Receptor Blockers and the Kidney: Possible Advantages over ACE Inhibition?

Cardiovascular drug reviews, 2001-03, Vol.19 (1), p.75-86

2001

Volltextzugriff (PDF)

Mercaptoacyl Dipeptides as Orally Active Dual Inhibitors of Angiotensin-Converting Enzyme and Neutral Endopeptidase

Journal of medicinal chemistry, 1996-08, Vol.39 (16), p.3158-3168

1996

Volltextzugriff (PDF)

CGS 27830, a potent nonpeptide endothelin receptor antagonist

Bioorganic & medicinal chemistry letters, 1993-10, Vol.3 (10), p.2099-2104

1993

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Aktive Filter

ThemaBiological And Medical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(48)

Sprache

Englisch
(48)
Japanisch
(9)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone

Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage

Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats

Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP

Renin inhibition with aliskiren : where are we now, and where are we going?

Increased renal production of angiotensin II and thromboxane B2 in conscious diabetic rats

Differences in AT2-receptor stimulation between AT1-receptor blockers valsartan and losartan quantified by renal interstitial fluid cGMP

Synergistic effects of combined converting enzyme inhibition and angiotensin II antagonism on blood pressure in conscious telemetered spontaneously hypertensive rats

Telemetric Monitoring of Cardiovascular Parameters in Conscious Spontaneously Hypertensive Rats

Combination of Low-Dose Valsartan and Enalapril Improves Endothelial Dysfunction and Coronary Reserve in Nω-Nitro-l-Arginine Methyl Ester–Treated Spontaneously Hypertensive Rats

Renal nitric oxide production is decreased in diabetic rats and improved by AT1 receptor blockade

Effects of Valsartan and Hydrochlorothiazide Alone and in Combination on Blood Pressure and Heart Rate in Conscious-Telemetered Spontaneously Hypertensive Rats (SHR)

The Angiotensin II Type 1 Receptor Mediates Renal Interstitial Content of Tumor Necrosis Factor-α in Diabetic Rats

Dipeptide sulfonamides as endothelin ETA/ETB receptor antagonists

Effects of the Novel Dual Inhibitor of Neutral Endopeptidase and Angiotensin-Converting Enzyme, CGS 30440, on Blood Pressure and Cardiac Hypertrophy in Spontaneously Hypertensive Rats

Hemodynamic Effects of Amlodipine and Benazeprilat in Spontaneously Hypertensive Rats

Effects of Aliskiren on Blood Pressure, Albuminuria, and (Pro)Renin Receptor Expression in Diabetic TG(mRen-2)27 Rats. Commentary

Functionally Distinct Endothelin B Receptors in Vascular Endothelium and Smooth Muscle

Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist. Effects on smooth muscle cell migration and proliferation after balloon catheter injury

Diaminoindanes as Microsomal Triglyceride Transfer Protein Inhibitors

Pharmacologic Profile of CGS 24128, a Potent, Long-Acting Inhibitor of Neutral Endopeptidase 24.11

Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats. Commentary

Angiotensin Receptor Blockers and the Kidney: Possible Advantages over ACE Inhibition?

Mercaptoacyl Dipeptides as Orally Active Dual Inhibitors of Angiotensin-Converting Enzyme and Neutral Endopeptidase

CGS 27830, a potent nonpeptide endothelin receptor antagonist

Aktive Filter

Suchergebnisse filtern